Current Neuro-Oncology

Volume 25 Number 9
15 May 2023

Home > Publications > Current Neuro-Oncology > Volume 25, Year 2023 > Number 9, 15 May

Sonabend AM, Gould A, Amidei C, Ward R, Schmidt KA, Zhang DY, Gomez C, Bebawy JF, Liu BP, Bouchoux G, Desseaux C, Helenowski IB, Lukas RV, Dixit K, Kumthekar P, Arrieta VA, Lesniak MS, Carpentier A, Zhang H, Muzzio M, Canney M, Stupp R.
Repeated blood-brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial.
Lancet Oncol. 2023 May;24(5):509-522. doi: 10.1016/S1470-2045(23)00112-2. PMID: 37142373. Interventional study˰ ˍ

Wang GB, Wang WX, Luo JJ.
Clinical effectiveness of sodium fluorescein-guided microsurgery in patients with high-grade gliomas.
Eur Rev Med Pharmacol Sci. 2023 May;27(9):3906-3913
. doi: 10.26355/eurrev_202305_32296. PMID: 37203814. Observational study. ˍ

Anvari K, Shahabadi M, Welsh JS, Javadinia SA, Zarei E.
Outcome of Second Line Treatment of Recurrent High- Grade Glioma by re-Irradiation or Bevacizumab-based Chemotherapy: A Cross Sectional Study.
Asian Pac J Cancer Prev. 2023 May 1;24(5):1507-1511. doi: 10.31557/APJCP.2023.24.5.1507. PMID: 37247269. Observational study. ˍ

Das A, Tabori U, Sambira Nahum LC, Collins NB, Deyell R, Dvir R, Faure-Conter C, Hassall TE, Minturn JE, Edwards M, Brookes E, Bianchi V, Levine A, Stone SC, Sudhaman S, Sanchez-Ramirez S, Ercan AB, Stengs L, Chung J, Negm L, Getz G, Maruvka YE, Ertl-Wagner B, Ohashi PS, Pugh T, Hawkins C, Bouffet E, Morgenstern DA.
Efficacy of nivolumab in pediatric cancers with high mutation burden and mismatch-repair deficiency.
Clin Cancer Res. 2023 May 1:CCR-23-0411. doi: 10.1158/1078-0432.CCR-23-0411. PMID: 37126021. Interventional study. ˍ

Warren KE, Vezina G, Krailo M, Springer L, Buxton A, Peer CJ, Figg WD, William-Hughes C, Kessel S, Fouladi M, Gajjar A, Bowers D.
Phase II Randomized Trial of Lenalidomide in Children With Pilocytic Astrocytomas and Optic Pathway Gliomas: A Report From the Children's Oncology Group.
J Clin Oncol. 2023 May 1:JCO2201777. doi: 10.1200/JCO.22.01777. PMID: 37126770. Interventional study˰ ˍ

Drexler R, Sauvigny T, Schüller U, Eckhardt A, Maire CL, Khatri R, Hausmann F, Hänzelmann S, Huber TB, Bonn S, Bode H, Lamszus K, Westphal M, Dührsen L, Ricklefs FL.
Epigenetic profiling reveals a strong association between lack of 5-ALA fluorescence and EGFR amplification in IDH-wildtype glioblastoma.
Neurooncol Pract. 2023 May 2;10(5):462-471
. doi: 10.1093/nop/npad025. PMID: 37720395. Observational study˰ ˍ

Hu P, Xu L, Qi Y, Yan T, Ye L, Wen S, Yuan D, Zhu X, Deng S, Liu X, Xu P, You R, Wang D, Liang S, Wu Y, Xu Y, Sun Q, Du S, Yuan Y, Deng G, Cheng J, Zhang D, Chen Q, Zhu X.
Combination of multi-modal MRI radiomics and liquid biopsy technique for preoperatively non-invasive diagnosis of glioma based on deep learning: protocol for a double-center, ambispective, diagnostical observational study.
Front Mol Neurosci. 2023 May 2;16:1183032
. doi: 10.3389/fnmol.2023.1183032. PMID: 37201155. Interventional study protocol. ˍ

Wu X, Alvarez-Breckenridge C.
Moving the Pendulum for Glioblastoma Treatment: One Injection at a Time.
Oncologist. 2023 May 2:oyad104. doi: 10.1093/oncolo/oyad104. PMID: 37130338. Comment. ˍ
REFERS TO: Todo T, et al., Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial.
Nat Med. 2022 Jul 21
. doi: 10.1038/s41591-022-01897-x. PMID: 35864254. Interventional study. ˍ

Zhang M, Xiao X, Gu G, Zhang P, Wu W, Wang Y, Pan C, Wang L, Li H, Wu Z, Zhang J, Zhang L.
Role of neuronavigation in the surgical management of brainstem gliomas.
Front Oncol. 2023 May 2;13:1159230
. doi: 10.3389/fonc.2023.1159230. PMID: 37205194. Observational study. ˍ

Krishna S, Choudhury A, Keough MB, Seo K, Ni L, Kakaizada S, Lee A, Aabedi A, Popova G, Lipkin B, Cao C, Nava Gonzales C, Sudharshan R, Egladyous A, Almeida N, Zhang Y, Molinaro AM, Venkatesh HS, Daniel AGS, Shamardani K, Hyer J, Chang EF, Findlay A, Phillips JJ, Nagarajan S, Raleigh DR, Brang D, Monje M, Hervey-Jumper SL.
Glioblastoma remodelling of human neural circuits decreases survival.
Nature. 2023 May 3;617(7961):599-607. doi: 10.1038/s41586-023-06036-1. PMID: 37138086. Laboratory investigation. ˍ

Ho C, Malicki D, Levy M, Crawford JR.
Unusual pattern of metastatic disease in a patient in their early childhood with group 4 medulloblastoma.
BMJ Case Rep. 2023 May 4;16(5):e253877. doi: 10.1136/bcr-2022-253877. PMID: 37142287. Case report. ˍ

Chen W, Jin S, Liu Q, Wang H, Xia Y, Guo X, Guo S, Wang Y, Shi Y, Liu D, Li Y, Wang Y, Xing H, Li J, Wu J, Liang T, Qu T, Li H, Yang T, Zhang K, Wang Y, Ma W.
Spotlights on adult patients with pediatric-type diffuse gliomas in accordance with the 2021 WHO classification of CNS tumors.
Front Neurosci. 2023 May 5;17:1144559
. doi: 10.3389/fnins.2023.1144559. PMID: 37214395. Observational study. ˍ

Jackson ER, Duchatel RJ, Staudt DE, Persson ML, Mannan A, Yadavilli S, Parackal S, Game S, Chong WC, Jayasekara WSN, Le Grand M, Kearney PS, Douglas AM, Findlay IJ, Germon ZP, McEwen HP, Beitaki TS, Patabendige A, Skerrett-Byrne DA, Nixon B, Smith ND, Day B, Manoharan N, Nagabushan S, Hansford JR, Govender D, McCowage GB, Firestein R, Howlett M, Endersby R, Gottardo NG, Alvaro F, Waszak SM, Larsen MR, Colino-Sanguino Y, Valdés-Mora F, Rakotomalala A, Meignan S, Pasquier E, Andre N, Hulleman E, Eisenstat DD, Vitanza NA, Nazarian J, Koschmann C, Mueller S, Cain JE, Dun MD.
ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma.
Cancer Res. 2023 May 5:CAN-23-0186. doi: 10.1158/0008-5472.CAN-23-0186. PMID: 37145169. Interventional study. ˍ

Burger MC, Forster MT, Romanski A, Straßheimer F, Macas J, Zeiner PS, Steidl E, Herkt S, Weber KJ, Schupp J, Lun JH, Strecker MI, Wlotzka K, Cakmak P, Opitz C, George R, Mildenberger IC, Nowakowska P, Zhang C, Röder J, Müller E, Ihrig K, Langen KJ, Rieger MA, Herrmann E, Bönig H, Harter PN, Reiss Y, Hattingen E, Rödel F, Plate KH, Tonn T, Senft C, Steinbach JP, Wels WS.
Intracranial injection of NK cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma.
Neuro Oncol. 2023 May 6:noad087. doi: 10.1093/neuonc/noad087. PMID: 37148198. Interventional study. ˍ

Neagu A, Niculae CM, Lăpădat I, Hristea A.
Challenges in the diagnosis of leptomeningeal dissemination of glioblastoma in a patient with fever and xanthochromic CSF: a case report.
Rom J Intern Med. 2023 May 6. doi: 10.2478/rjim-2023-0010. PMID: 37148304. Case report. ˍ

Hertler C, Felsberg J, Gramatzki D, Le Rhun E, Clarke J, Soffietti R, Wick W, Chinot O, Ducray F, Roth P, McDonald K, Hau P, Hottinger AF, Reijneveld J, Schnell O, Marosi C, Glantz M, Darlix A, Lombardi G, Krex D, Glas M, Reardon DA, van den Bent M, Lefranc F, Herrlinger U, Razis E, Carpentier AF, Phillips S, Rudà R, Wick A, Tabouret E, Meyronet D, Maurage CA, Rushing E, Rapkins R, Bumes E, Hegi M, Weyerbrock A, Aregawi D, Gonzalez-Gomez C, Pellerino A, Klein M, Preusser M, Bendszus M, Golfinopoulos V, von Deimling A, Gorlia T, Wen PY, Reifenberger G, Weller M.
Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders' Collaborative Consortium (EORTC 1419).
Eur J Cancer. 2023 May 8:S0959-8049(23)00230-7. doi: 10.1016/j.ejca.2023.05.002. PMID: 37277265. Observational study. ˍ

Sozer A, Borcek AO, Sagiroglu S, Poshtkouh A, Demirtas Z, Karaaslan MM, Kuzucu P, Celtikci E.
The first case of glioma detected by an artificial intelligence algorithm running on real-time data in neurosurgery: illustrative case.
J Neurosurg Case Lessons. 2023 May 8;5(19):CASE22536. doi: 10.3171/CASE22536? PMID: 37158388. Case report. ˍ

Zohdy YM, Agam M, Maldonado J, Jahangiri A, Pradilla G, Garzon-Muvdi T.
Symptomatic intracranial tumors in pregnancy: an updated management algorithm. Illustrative case.
J Neurosurg Case Lessons. 2023 May 8;5(19):CASE2399. doi: 10.3171/CASE2399? PMID: 37158391. Case report. ˍ

Alimohamadi M, Pour-Rashidi A, Larijani A, Rahmani M, Hendi K, Shariat Moharari R, Raminfard S, Ajam H, Gerganov V.
Perioperative seizure in patients undergoing brain mapping under awake craniotomy for language-related eloquent region gliomas: a prospective study.
J Neurosurg Sci. 2023 May 9. doi: 10.23736/S0390-5616.22.05675-2. PMID: 37158710. Interventional study˰ ˍ

Semeraro M, Fouquet C, Vial Y, Amiel J, Galmiche L, Cretolle C, Blanc T, Jolaine V, Garcelon N, Entz-Werle N, Pellier I, Vérité C, SophieTaque, Coulomb A, Petit A, Corradini N, Bouazza N, Lacour B, Clavel J, Brugières L, Bourdeaut F, Sarnacki S; members of the TED consortium.
Pediatric Tumors and Developmental Anomalies: A French Nationwide Cohort Study.
J Pediatr. 2023 May 9:113451. doi: 10.1016/j.jpeds.2023.113451. PMID: 37169337. Observational study˰ ˍ

Riviere-Cazaux C, Lacey JM, Carlstrom LP, Laxen WJ, Munoz-Casabella A, Hoplin MD, Ikram S, Zubair AB, Andersen KM, Warrington AE, Decker PA, Kaufmann TJ, Campian JL, Eckel-Passow JE, Kizilbash SH, Tortorelli S, Burns TC.
Cerebrospinal fluid 2-hydroxyglutarate as a monitoring biomarker for IDH-mutant gliomas.
Neurooncol Adv. 2023 May 11;5(1):vdad061. doi: 10.1093/noajnl/vdad061. PMID: 37313502. Interventional study. ˍ

Blobner J, Dengler L, Blobner S, Eberle C, Weller J, Teske N, Karschnia P, Rühlmann K, Heinrich K, Ziemann F, Greif PA, Jeremias I, Wuerstlein R, Hasselmann K, Dorostkar M, Harter PN, Quach S, Stoecklein V, Albert NL, Niyazi M, Tonn JC, Thon N, Christoph Westphalen B, von Baumgarten L.
Significance of molecular diagnostics for therapeutic decision-making in recurrent glioma.
Neurooncol Adv. 2023 May 12;5(1):vdad060. doi: 10.1093/noajnl/vdad060. PMID: 37287694. Observational study. ˍ


Ranjan T, Yu A, Elhamdani S, Howard CM, Lirette ST, Denning KL, Valluri J, Claudio PP.
Treatment of unmethylated MGMT-promoter recurrent glioblastoma with cancer stem cell assay-guided chemotherapy and the impact on patients' healthcare costs.
Neurooncol Adv. 2023 May 12;5(1):vdad055. doi: 10.1093/noajnl/vdad055. PMID: 37287692. Observational study. ˍ

Wang R, Cui J, Diao Y, Jin C, Chen Y, Lv X, Li X.
Risk factor analysis and nomogram establishment and verification of brain astrocytoma patients based on SEER database.
Sci Rep. 2023 May 12;13(1):7754. doi: 10.1038/s41598-023-33537-w. PMID: 37173353. Observational study. ˍ

Yu X, Hong W, Ye M, Lai M, Shi C, Li L, Ye K, Xu J, Ai R, Shan C, Cai L, Luo L.
Atypical primary central nervous system lymphoma and glioblastoma: multiparametric differentiation based on non-enhancing volume, apparent diffusion coefficient, and arterial spin labeling.
Eur Radiol. 2023 May 12
. doi: 10.1007/s00330-023-09681-2. PMID: 37171492. Observational study. ˍ

Zilioli A, Misirocchi F, Mutti C, Pancaldi B, Mannini E, Spallazzi M, Parrino L, Cerasti D, Michiara M, Florindo I.
Volumetric hippocampal changes in glioblastoma: a biomarker for neuroplasticity?
J Neurooncol. 2023 May 13. doi: 10.1007/s11060-023-04315-5. PMID: 37178276. Observational study. ˍ

Al-Romaihi N, Awadh M, Albalooshi M, Ahmed M, Darwish A.
Clinicopathological and Immunohistochemistry Study of a Long Survivor of Giant Cell Glioblastoma in a Patient With Neurofibromatosis 1: Case Report.
Cureus. 2023 May 14;15(5):e39014. doi: 10.7759/cureus.39014. PMID: 37323350. Case report. ˍ

Oblitas López S, Bocanegra-Becerra JE, Castillo-Huerta NM, Ludeña-Esquivel A, Becerra Zegarra A.
Awake Craniotomy for Resection of Diffuse Astrocytoma During Pregnancy: A Case Report.
Cureus. 2023 May 14;15(5):e39016. doi: 10.7759/cureus.39016. PMID: 37378163. Case report. ˍ

Knight A, Horsley P, Yuile A, Yim J, Suh M, Venketesha V, Kastelan M, Wheeler H, Back M.
Volumetric response and pattern of failure of histone altered high grade glioma in adults following management with radiation therapy.
J Neurooncol. 2023 May 15
. doi: 10.1007/s11060-023-04332-4. PMID: 37184742. Observational study˰ ˍ

Nassiri F, Patil V, Yefet LS, Singh O, Liu J, Dang RMA, Yamaguchi TN, Daras M, Cloughesy TF, Colman H, Kumthekar PU, Chen CC, Aiken R, Groves MD, Ong SS, Ramakrishna R, Vogelbaum MA, Khagi S, Kaley T, Melear JM, Peereboom DM, Rodriguez A, Yankelevich M, Nair SG, Puduvalli VK, Aldape K, Gao A, López-Janeiro Á, de Andrea CE, Alonso MM, Boutros P, Robbins J, Mason WP, Sonabend AM, Stupp R, Fueyo J, Gomez-Manzano C, Lang FF, Zadeh G.
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.
Nat Med. 2023 May 15
. doi: 10.1038/s41591-023-02347-y. PMID: 37188783. Interventional study. ˍ

Tuleasca C, Leroy HA, Strachowski O, Derre B, Maurage CA, Peciu-Florianu I, Reyns N.
Combined use of intraoperative MRI and awake tailored microsurgical resection to respect functional neural networks: preliminary experience.
Swiss Med Wkly. 2023 May 15;153:40072
. doi: 10.57187/smw.2023.40072. PMID: 37192405. Observational study. ˍ

Zakharova NE, Batalov AI, Pogosbekian EL, Chekhonin IV, Goryaynov SA, Bykanov AE, Tyurina AN, Galstyan SA, Nikitin PV, Fadeeva LM, Usachev DY, Pronin IN.
Perifocal Zone of Brain Gliomas: Application of Diffusion Kurtosis and Perfusion MRI Values for Tumor Invasion Border Determination.
Cancers (Basel). 2023 May 15;15(10):2760. doi: 10.3390/cancers15102760. PMID: 37345097. Observational study. ˍ